Leading experts to shape the future of Viz.ai’s HCM strategy and platform
Honored for excellence in innovation in AI Assisted Medicine
Only company in healthcare to be recognized for the fourth time
Tailored for trauma care providers to help expedite patient care and improve outcomes
New artificial intelligence algorithm flags and triages suspected abdominal aortic aneurysms
Annual list recognizes innovative medtech companies that are advancing the art and science of healthcare
Viz.ai’s AI-powered clinical research platform will be used to find, screen and enroll patients in a landmark study of catheter-directed therapy for pulmonary embolism
Viz.ai has submitted a de novo classification request to the FDA for a new AI algorithm intended to identify and triage patients suspected with HCM
Using Viz RECRUIT software, recruitment happens in real-time, around-the-clock, accelerating treatment development for patients with intracerebral hemorrhage
Study, across 166 facilities in 17 states, finds AI-powered care coordination crucial for acute stroke management
End-to-end platform for vascular care teams to accelerate the detection and treatment of suspected vascular disease
Healthcare technology leader recognized for its culture, diversity, career growth and outlook
New partnership incorporates latest perfusion technology into the Viz.ai platform
Leading experts to help shape the future of Viz.ai’s radiology strategy and platform
Comprehensive solution tailored for radiologists to expedite patient diagnosis and treatment
Validates the Viz Aortic Dissection Detection algorithm with high sensitivity, specificity and positive predictive value.
Partnership to accelerate enrollment and diversity in neurovascular clinical research.
Adds natural language processing to Viz.ai’s AI-powered platform to detect suspected disease earlier and monitor patients.
Median size of aneurysms was 5mm, suggesting that AI-powered detection of incidental cerebral aneurysms can improve patient care pathways.
Comprehensive solution tailored for cardiovascular care teams to improve care pathways and grow referrals
Partnership delivers critical insights to cardiac care teams for faster patient triage and care.
AngioDynamics, The PERT Consortium™ and Viz.ai partner on APEX Study to facilitate future enrollment to bring innovative treatment to patients with PE
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has named life sciences veteran Jieun Choe as chief marketing officer (CMO).
Part of the Viz PE Solution, new algorithm flags key patient risk indicator of pulmonary embolism severity.
AI-powered Viz SUBDURAL (SDH) automatically detects subdural hemorrhage, enables effective triage and optimal care
Viz.ai announced today it is partnering with Hyperfine, Inc., creator of the first FDA-cleared point-of-care magnetic resonance imaging (MRI) device, Swoop®.
Round will fuel global expansion of AI-driven healthcare platform that accelerates access to life saving treatments
Viz.ai, the world leader in artificial intelligence (AI) powered care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for Viz ANEURYSM.
Data from several new studies presented this week at the International Stroke Conference (ISC) further validates the best-in-class sensitivity and specificity of Viz.ai’s intelligent care coordination platform for stroke in real world settings across multiple commercial modules.
Viz.ai and TeleSpecialists, LLC have entered a strategic partnership that will bring AI-powered stroke care together with leading telestroke neurologists to optimize time to treatment and improve patient outcomes across the United States.
Viz.ai is the leader in AI-powered care coordination and has accelerated the time-to-notification of the treatment team by 73 percent and time-to-treatment by percent. The Viz Platform is now utilized in over 850 hospitals across the U.S. and Europe and touches almost two patients every minute.
Diagnosis and care coordination of patients suffering from pulmonary embolism (PE) can be challenging, with the average arrival-to-treatment times lasting more than 8 hours. Viz.ai uses deep learning to identify suspected pulmonary embolism disease in under two minutes.
Viz.ai, the world leader in AI-driven intelligent care coordination, has received a New Technology Add-on Payment (NTAP) renewal from Centers for Medicare & Medicaid Services (CMS) for its AI-powered stroke triage module, Viz LVO (formerly known as Viz ContaCT).
Viz.ai, the world leader in AI-driven intelligent care coordination, haspartnered with Avicenna.AI, a global leader in artificialintelligence solutions, to enable intelligent care coordination andimprove patient triage of patients suffering from pulmonary embolism (PE) andaortic disease.
Viz.ai has been awarded a CE Mark for its artificial intelligence (AI) powered stroke care software, affirming its conformity with European health, safety and environmental protection standards for products sold within the European Economic Area.
Viz.ai today announced new data supporting the use of its technology to coordinate care for acute ischemic stroke, hemorrhagic stroke, and clinical trial recruitment at the 2021 International Stroke Conference. Dr. Ameer E. Hassan of the Valley Baptist Medical Center in Texas presented...
Viz.ai today announced that it has raised $71 million in Series C funding, led by Scale Venture Partners and Insight Partners with participation from Greenoaks, Kleiner Perkins, Threshold Ventures, CRV, Innovation Endeavors and Susa Ventures. Viz.ai aims to accelerate expansion...
WORLD STROKE DAY -Today, on World Stroke Day, many prominent health systems such as Banner Health, Ohio State University Medical Center, Atrium Health, and Piedmont Healthcare are using artificial intelligence (AI) powered synchronized stroke solutions from Viz.ai to expedite care...
A.I. healthcare company, Viz.ai, has won the prestigious UCSF Digital Health Award for Best New Application of A.I. On the heels of receiving the first New Technology Add-on Payment from CMS for an A.I. powered software system, this award further validates the real world benefits Viz.ai...
Viz.ai, the leading AI stroke platform, is the first AI software to receive a Medicare New Technology Add-on Payment, helping hospitals adopt advanced technology to improve stroke care
NICO Corp. to install Viz Recruit, an AI based clinical trial enrollment platform at ENRICH sites to increase enrollment rates and reduce time to randomization in intracerebral hemorrhage (ICH).
Viz.ai, Inc., is the first artificial intelligence company recognized as an American Heart Association/American Stroke Association Get with the Guidelines Compatible Vendor